No Data
No Data
Shareholder Alert: Ademi LLP Investigates Disclosure Issues Involving ARCA Biopharma, Inc.'s Transaction With Oruka
MILWAUKEE, June 4, 2024 /PRNewswire/ -- Ademi LLP is investigating ARCA (NASDAQ: ABIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Oruka. Click here to
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 70.4% to $3.51 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 million. Molecular Partners (NASDA
Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply With IVDR Regulation
GameStop Trader 'Roaring Kitty' Sparks Wall Street Rally In Heavily Shorted Stocks: What You Need To Know Right Now
Several stocks with high short interest rallied on Monday following an incredible surge in GameStop Corp (NYSE:GME) shares. Here's a quick look at what you need to know.What To Know: The madness in me
ARCA Biopharma (ABIO.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -$0.14, previous value of -$0.09.
ARCA Biopharma (ABIO.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $0; earnings per share of -$0.14, previous value of -$0.09.
ARCA Biopharma Q1 EPS $(0.14) Down From $(0.09) YoY
ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.14) per share. This is a 55.56 percent decrease over losses of $(0.09) per share from the same period last year.